| Date | Title | Description |
| 22.08.2025 | DeepIntent Launches Free Ad Supported TV (FAST) Solution | DeepIntent, the leading healthcare advertising platform, today announced the release of its HealthFirst™ FAST (Free Ad Supported Streaming TV) Package, a performance-driven solution delivering premium, scalable access for healthcare adverti... |
| 27.03.2025 | Unraveling the Genetic Threads of Bipolar Disorder and the Future of Healthcare Advertising | In the intricate tapestry of human health, two recent developments stand out. One reveals the genetic underpinnings of bipolar disorder, while the other transforms healthcare advertising through cutting-edge technology. Together, they highl... |
| 26.03.2025 | DeepIntent Unveils DeepIntent Cortex™ | DeepIntent, the leading healthcare advertising technology company, today introduced DeepIntent Cortex, its most advanced demand side platform (DSP) upgrade to date. Inspired by the human brain’s ability to process complex information, DeepI... |
| 24.08.2024 | DeepIntent and Bloomingdale's: Two Giants Transforming Their Industries | In the bustling world of marketing and retail, two companies are making waves. DeepIntent, a health advertising platform, has launched The DeepDive, a resource hub tailored for healthcare marketers. Meanwhile, Bloomingdale's is set to unvei... |
| 21.08.2024 | DeepIntent Launches The DeepDive: An Industry-First Resource Hub for Healthcare Marketers | Featuring exclusive insights, professional development opportunities, and industry-first resources, The DeepDive empowers healthcare marketers to excel in an increasingly competitive landscape.
NEW YORK, Aug. 21, 2024 /PRNewswire/ -- DeepIn... |
| 26.04.2024 | Acxiom and DeepIntent introduce direct data integration | Acxiom, the global leader in customer intelligence, today announced its strategic integration with DeepIntent, the healthcare advertising platform.
Healthcare brands, marketers, and agencies can use DeepIntent’s Demand Side Platform (DSP) t... |
| 03.06.2022 | Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO gig | In the latest development over alleged patent infringement related to Pfizer’s and Moderna’s mRNA vaccines for Covid-19, Pfizer is stepping up to the plate and sharing its side of the story.
RNAi therapeutics giant Alnylam knew before it fi... |
| 03.06.2022 | Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO gig | Some companies celebrate anniversaries with cake and a party. Women’s health pharma Organon is celebrating its 1-year spinoff from Merck by introducing a series of vibrant murals at different global facilities and putting an environmental, ... |
| 03.06.2022 | Time Passages: Bruce Goldsmith out at Jim Wilson's gene therapy biotech; Flagship reveals Michael Severino’s CEO gig | Biogen and their biosimilar partners at Samsung Bioepis are rolling out their copycat version of Roche’s anti-VEGF blockbuster Lucentis today, 8 months after it was approved by the FDA. And they’re planning to dive straight into a wet AMD m... |
| 02.06.2022 | Novartis resumes remote business in Ukraine after safety protocol review | Months after a slate of pharma companies slammed the brakes on some operations in both Russia and Ukraine, Novartis announced that it’s resuming business remotely in Ukraine “to help the war-torn country restore some basi... |
| 02.06.2022 | Even at $2M+, ICER calls bluebird's potential gene therapy for blood disorder 'superior' to standard of care | The Institute for Clinical and Economic Review, a drug pricing watchdog, gave a measured thumbs up on Thursday morning to bluebird’s potentially expensive new gene therapy for a rare but debilitating blood disorder... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | When talking about genomics biotechs, financing rounds tend to be more on the modest side — an $18.5 million Series A round for one, $21 million venture equity financing raise for another, and $98 million for Alice Zhang’s Verge Genomics Se... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | Passage Bio’s ambitions will be handled by a new face going forward as Bruce Goldsmith exited Tuesday, adding to the list of biotechs facing the unrelenting bear market that has forced leadership shuffles to happen at breakneck speed.
The b... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | Pharma TV ad critics often complain about too many commercials or too little creativity, but the bottom line is, it works. Pharma commercials are still driving people to action, according to new research.
More than one in four (27%) talked ... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | Pascal Soriot’s victory lap leading up to his 10th anniversary as CEO of a radically transformed AstraZeneca comes with a knighthood.
Soriot — born and raised in France, head of a Cambridge, UK-based pharma giant and a citizen of Australia ... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | After Samantha Truex shut down Quench Bio early last year, she knew she wanted to get back into the biotech world and run another company. The path just ended up more winding than initially expected.
Truex had joined Atlas Ventures a couple... |
| 01.06.2022 | Changing course, Pfizer decides to sell off stake in GSK's consumer health spinoff | GSK’s consumer health spinoff Haleon is expected to list on the London stock exchange next month. But don’t expect Pfizer to stick along for the ride.
Pfizer announced on Wednesday that it plans on exiting its 32% stake in Ha... |
| 01.06.2022 | Longtime Pfizer vet tapped to replace legendary vaccine researcher Kathrin Jansen | Stand Up To Cancer is well-known for its celebrity connections and gala fundraising events, but in pharma and biotech, it’s also known as a research partner. Its two recently added teams partner with Bristol Myers Squibb on lung cancer disp... |
| 01.06.2022 | Sage and Biogen build out case for depression drug as it passes PhIII test in postpartum women | Sage Therapeutics and Biogen are continuing a march forward in the depression space and have new data that they hope will wow investors and the FDA alike.
A Phase III study of zuranolone met all its primary and key secondar... |
| 01.06.2022 | Trailing AstraZeneca in lupus, Bristol Myers looks to push TYK2 drug into PhIII trials | In the past year, AstraZeneca has won US and EU approvals for its lupus antibody Saphnelo, which became the first new lupus drug to get approved since GSK’s Benlysta in 2011.
Lagging behind, Bristol Myers Squibb has also been... |
| 01.06.2022 | Bavarian Nordic continues to increase 2022 revenue projections as monkeypox spreads | The spread of monkeypox, although not on the scale of the ongoing Covid-19 pandemic, has helped Danish drugmaker Bavarian Nordic benefit from its smallpox vaccine.
As a result of vaccine orders from around the world, Bava... |
| 19.05.2022 | How Pharma Brand Managers Can Get Started With Programmatic CTV Advertising | Chris Paquette is CEO at DeepIntent, the leading healthcare marketing technology company created to influence positive health outcomes. |
| 27.10.2021 | 16 Leaders Share Tips To Help Young Tech Professionals Find The Right Mentor | getty |
| 18.05.2021 | DeepIntent Expands Healthcare Marketplace By Integrating Major Supply Sources | |
| 06.04.2021 | DeepIntent® Launches DeepIntent Outcomes™ | |
| 05.03.2021 | The New CEO: How The Events Of 2020 Changed The Meaning Of Leadership | Chris Paquette is CEO at DeepIntent, the leading healthcare marketing technology company created to influence positive health outcomes. |
| 08.02.2021 | Why The Vaccine Is A Shot In The Arm For Healthcare Marketers | Chris Paquette is CEO at DeepIntent, the leading healthcare marketing technology company purpose-built to influence positive health outcomes |
| 04.02.2021 | 13 Cutting-Edge Technologies That May Soon Be Making A Big Impact | getty |
| 15.12.2020 | DeepIntent Continues Significant Growth And Expansion As Demand For Healthcare Marketing Platform Reaches Inflection Point | |
| 07.12.2020 | From The Experts: Media And Advertising In 2021 | The short-lived Quibi was one of the casualties of the pandemic ridden 2020, nonetheless many media ... [+] experts expects 2021 to be banner year for connected TV devices and streaming video. Photographer: David Paul Morris/Bloomberg© 2020... |
